Home LiteratureArticle Details
PMID: 3550423 Published · ppublish English Journal Article

Biochemical and biological properties of the human N-ras p21 protein.

Molecular and cellular biology ·Vol. 7 ·No. 1 ·1987-01-00 ·Pages 541-4

Trahey M, Milley RJ, Cole GE, Innis M, Paterson H, Marshall CJ, Hall A, McCormick F

Abstract

We characterized the normal (Gly-12) and two mutant (Asp-12 and Val-12) forms of human N-ras proteins produced by Escherichia coli. No significant differences were found between normal and mutant p21 proteins in their affinities for GTP or GDP. Examination of GTPase activities revealed significant differences between the mutant p21s: the Val-12 mutant retained 12% of wild-type GTPase activity, whereas the Asp-12 mutant retained 43%. Both mutant proteins, however, were equally potent in causing morphological transformation and increased cell motility after their microinjection into quiescent NIH 3T3 cells. This lack of correlation between transforming potency and GTPase activity or guanine nucleotide binding suggests that position 12 mutations affect other aspects of p21 function.

MeSH Terms
Animals Cell Transformation, Neoplastic Cells, Cultured Escherichia coli/genetics GTP Phosphohydrolases/metabolism Guanosine Diphosphate/metabolism Guanosine Triphosphate/metabolism Humans Mice Mutation Oncogenes Protein Binding Proto-Oncogene Proteins/genetics,metabolism Proto-Oncogene Proteins p21(ras)
Chemicals
Proto-Oncogene Proteins Guanosine Diphosphate Guanosine Triphosphate GTP Phosphohydrolases HRAS protein, human Proto-Oncogene Proteins p21(ras)
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Trahey M
Milley R J
Cole G E
Innis M
Paterson H
Marshall C J
Hall A
McCormick F
References (36)
36 references, click to expand
  1. Biological and biochemical properties of human rasH genes mutated at codon 61.
    Cell. 1986 Jan 17;44(1):167-76 PMID: 3510078
  2. Biochemical properties of a highly purified v-rasH p21 protein overproduced in Escherichia coli and inhibition of its activities by a monoclonal antibody.
    Mol Cell Biol. 1985 Jun;5(6):1449-55 PMID: 3162096
  3. Mutant ras-encoded proteins with altered nucleotide binding exert dominant biological effects.
    Proc Natl Acad Sci U S A. 1986 Feb;83(4):952-6 PMID: 3513168
  4. The oncogenic activation of human p21ras by a novel mechanism.
    Science. 1986 Aug 8;233(4764):649-52 PMID: 3487832
  5. Biochemical characterization of polypeptides encoded by mutated human Ha-ras1 genes.
    Mol Cell Biol. 1986 Feb;6(2):730-4 PMID: 3537694
  6. Protein measurement with the Folin phenol reagent.
    J Biol Chem. 1951 Nov;193(1):265-75 PMID: 14907713
  7. Catalytic properties of the SV40 large T antigen.
    Cold Spring Harb Symp Quant Biol. 1980;44 Pt 1,:103-11 PMID: 6253123
  8. Guanine nucleotide-binding and autophosphorylating activities associated with the p21src protein of Harvey murine sarcoma virus.
    Nature. 1980 Oct 23;287(5784):686-91 PMID: 6253810
  9. Guanine nucleotide binding activity of the src gene product of rat-derived murine sarcoma viruses.
    Ann N Y Acad Sci. 1980;354:398-409 PMID: 6261655
  10. Human EJ bladder carcinoma oncogene is homologue of Harvey sarcoma virus ras gene.
    Nature. 1982 Jun 10;297(5866):474-8 PMID: 6283357
  11. T24 human bladder carcinoma oncogene is an activated form of the normal human homologue of BALB- and Harvey-MSV transforming genes.
    Nature. 1982 Jul 22;298(5872):343-7 PMID: 6283384
  12. Transforming genes of human bladder and lung carcinoma cell lines are homologous to the ras genes of Harvey and Kirsten sarcoma viruses.
    Proc Natl Acad Sci U S A. 1982 Jun;79(11):3637-40 PMID: 6285355
  13. Mechanism of activation of a human oncogene.
    Nature. 1982 Nov 11;300(5888):143-9 PMID: 6290897
  14. A point mutation is responsible for the acquisition of transforming properties by the T24 human bladder carcinoma oncogene.
    Nature. 1982 Nov 11;300(5888):149-52 PMID: 7133135
  15. Three human transforming genes are related to the viral ras oncogenes.
    Proc Natl Acad Sci U S A. 1983 Apr;80(8):2112-6 PMID: 6572964
  16. Acquisition of transforming properties by alternative point mutations within c-bas/has human proto-oncogene.
    Nature. 1983 Jun 30;303(5920):775-9 PMID: 6866079
  17. Structure of the Ki-ras gene of the human lung carcinoma cell line Calu-1.
    Nature. 1983 Aug 11-17;304(5926):497-500 PMID: 6308465
  18. Activation of Ki-ras2 gene in human colon and lung carcinomas by two different point mutations.
    Nature. 1983 Aug 11-17;304(5926):507-13 PMID: 6308467
  19. Microinjection of tissue culture cells.
    Methods Enzymol. 1983;101:482-92 PMID: 6310338
  20. Analysis of the transforming potential of the human H-ras gene by random mutagenesis.
    Proc Natl Acad Sci U S A. 1984 Jul;81(13):4008-12 PMID: 6330729
  21. Transformation of NIH 3T3 cells by microinjection of Ha-ras p21 protein.
    Nature. 1984 Aug 9-15;310(5977):508-11 PMID: 6611509
  22. Microinjection of the oncogene form of the human H-ras (T-24) protein results in rapid proliferation of quiescent cells.
    Cell. 1984 Aug;38(1):109-17 PMID: 6380758
  23. Comparative biochemical properties of normal and activated human ras p21 protein.
    Nature. 1984 Aug 23-29;310(5979):644-9 PMID: 6147754
  24. The product of ras is a GTPase and the T24 oncogenic mutant is deficient in this activity.
    Nature. 1984 Sep 20-26;311(5983):273-5 PMID: 6148703
  25. Site-specific mutagenesis of the human fibroblast interferon gene.
    Proc Natl Acad Sci U S A. 1984 Sep;81(18):5662-6 PMID: 6091102
  26. Intrinsic GTPase activity distinguishes normal and oncogenic ras p21 molecules.
    Proc Natl Acad Sci U S A. 1984 Sep;81(18):5704-8 PMID: 6148751
  27. Human colon carcinoma Ki-ras2 oncogene and its corresponding proto-oncogene.
    Mol Cell Biol. 1984 Aug;4(8):1577-82 PMID: 6092920
  28. Guanosine nucleotide binding by highly purified Ha-ras-encoded p21 protein produced in Escherichia coli.
    Proc Natl Acad Sci U S A. 1984 Nov;81(22):6953-7 PMID: 6438627
  29. Ha-ras proteins exhibit GTPase activity: point mutations that activate Ha-ras gene products result in decreased GTPase activity.
    Proc Natl Acad Sci U S A. 1985 Jan;82(2):376-80 PMID: 2982154
  30. Activation of an N-ras gene in acute myeloblastic leukemia through somatic mutation in the first exon.
    Proc Natl Acad Sci U S A. 1985 Feb;82(3):879-82 PMID: 3856237
  31. Viral Harvey ras p21 expressed in Escherichia coli purifies as a binary one-to-one complex with GDP.
    J Biol Chem. 1985 Apr 10;260(7):3906-9 PMID: 2984188
  32. Purification and characterization of human H-ras proteins expressed in Escherichia coli.
    Mol Cell Biol. 1985 May;5(5):1015-24 PMID: 3923330
  33. Amino-acid substitutions at codon 13 of the N-ras oncogene in human acute myeloid leukaemia.
    Nature. 1985 Jun 27-Jul 3;315(6022):726-30 PMID: 2989702
  34. Human N-ras: cDNA cloning and gene structure.
    Nucleic Acids Res. 1985 Jul 25;13(14):5255-68 PMID: 2991860
  35. p21ras. Heterogeneous localization in transformed cells.
    Exp Cell Res. 1985 Aug;159(2):441-50 PMID: 3896830
  36. Ras p21 proteins with high or low GTPase activity can efficiently transform NIH/3T3 cells.
    Cell. 1986 Feb 28;44(4):609-17 PMID: 3004741
Article Info
Journal
Molecular and cellular biology
Abbr.
Mol Cell Biol
ISSN
0270-7306
Published
1987-01-00
Pages
541-4
Language
English
Region
United States
NLM ID
8109087
PMCID
PMC365100
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]